We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

News · July 06, 2022

Risk for Neurodegenerative, Cerebrovascular Diseases Higher for COVID-19-Positive Patients

However, risk for Alzheimer, Parkinson disease after COVID-19 similar to risk after influenza or other respiratory diseases

PracticeUpdate Editorial Team

 

Further Reading